SwissEdilab has sold the brands Colon Pure & Ail Noir Oxyprotect to Noreva Pharma
SwissEdilab, a firm specialized in distribution of food supplements, has sold the brands Colon Pure and Ail Noir Oxyprotect to Noreva Pharma.
Noreva Pharma is a French cosmetics laboratory specialized in the development of dermatological care products distributed in drug stores.
This strategic acquisition expands the firm's product range distributed by its sales force. Noreva Pharma, which is very active in the OTC health market in France, had already acquired Phythea in 2016 and the Bergasol brand from Omega Pharma in 2018.
Oaklins' team in France was the sell-side advisor for SwissEdilab in this transaction.
Talk to the deal team
Related deals
Acquisition in the fruit and vegetable retail industry
Grupo Agris has acquired Ludite. This acquisition enables Grupo Agris to reinforce its expansion plan through business diversification and market consolidation.
Learn morePental Limited has divested its consumer products business to Dulux Group
Pental Limited (ASX:PTL), a trusted Australian provider of household chemical and cleaning products, has divested its consumer products business to DuluxGroup Limited.
Learn moreMerger of Goedhuis & Co and Waddesdon Wine
Goedhuis & Co has merged with Waddesdon Wine. Both companies will initially continue to trade under their existing names while the two businesses are fully integrated, to ensure no disruption to clients or suppliers.
Learn more